Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells

Anticancer Research

Volumn 25, Issue 3 A, 2005, Pages 1803-1810

  Zieglschmid, Veit ^a   Hollmann, Christiane ^a   Gutierrez, Bertha ^a   Albert, Winfried ^a   Strothoff, Dark ^b   Gross, Eberhard ^b   Böcher, Oliver ^a  

^a AdnaGen AG   (Germany)

^b ASKLEPIOS HOSPITAL BARMBEK   (Germany)

Author keywords

Disseminated tumor cells; Immunomagnetic selection; Multiplex RT PCR

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPITHELIAL CELL ADHESION MOLECULE;

BREAST CANCER; CANCER DIAGNOSIS; COLORECTAL CANCER; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMAGNETIC SEPARATION; PRIORITY JOURNAL; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TESTIS CANCER; TIME SERIES ANALYSIS; TUMOR CELL;

HUMANS; IMMUNOMAGNETIC SEPARATION; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 21244499767     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (29)

1. Zach O, Kasparu H, Wagner H, Krieger O and Lutz D: Prognostic value of tumour cell detection in peripheral blood of breast cancer patients. Acta Med Austriaca 29: 32-34, 2002.
2. Brandt B, Schmitt H, Feldner JC, Lelle RJ, Semjonow A and Beckmann A: Blood-borne cancer cells-quo vadis? Int J Biol Markers 15: 111-113, 2000.
3. Jiang WG, Martin TA and Mansel RE: Molecular detection of micro-metastasis in breast cancer. Crit Rev Oncol Hematol 43: 13-31, 2002.
4. Weiss L: Metastatic inefficiency. Adv Cancer Res 54: 159-211, 1990.
5. Glaves D, Huben RP and Weiss L: Haematogenous dissemination of cells from human renal adenocarcinomas. Br J Cancer 57: 32-35, 1988.
6. Pantel K and Otte M: Disseminated tumor cells: diagnosis, prognostic relevance, and phenotyping. Rec Results Cancer Res 158: 14-24, 2001.
7. Baker M, Gillanders WE, Mikhitarian K, Mitas M and Cole DJ: The molecular detection of micrometastatic breast cancer. Am J Surg 186: 351-358, 2003.
8. Vlems FA, Wobbes T, Punt CJ and Van Muijen GN: Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer. Anticancer Res 23: 523-530, 2003.
9. Hampton R, Walker M, Marshall J and Juhl H: Differential expression of carcinoembryonic antigen (CEA) splice variants in whole blood of colon cancer patients and healthy volunteers: implication for the detection of circulating colon cancer cells. Oncogene 21: 7817-7823, 2002.
10. Zippelius A and Pantel K: RT-PCR-based detection of occult disseminated tumor cells in peripheral blood and bone marrow of patients with solid tumors. An overview. Ann NY Acad Sci 906: 110-123, 2000.
11. Normanno N, De Luca A, Castaldo A, Casamassimi A, Di Popolo A, Zarrilli R, Porcellini A, Acquaviva AM, Avvedimento VE and Pignata S: Apolipoprotein A-I reverse transcriptase-polymerase chain reaction analysis for detection of hematogenous colon cancer dissemination. Int J Oncol 13: 443-447, 1998.
12. Kantor AB, Gibbons I, Miltenyi S and Schmitz J: Magnetic cell sorting with colloidal superparamagnetic particles. Cell Sep Meth Appl 153-173, 1998.
13. Tsavellas G, Patel H and Allen-Mersh TG: Detection and clinical significance of occult tumour cells in colorectal cancer. Br J Surg 88: 1307-1320, 2001.
14. Bertucci F, Viens P, Hingamp P, Nasser V, Houlgatte R and Birnbaum D: Breast cancer revisited using DNA array-based gene expression profiling. Int J Cancer 103: 565-571, 2003.
15. Klein CA, Blankenstein TJ, Schmidt-Kittler O, Petronio M, Polzer B, Stoecklein NH and Riethmuller G: Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer. Lancet 360: 683-689, 2002.
16. Braun S, Hepp F, Sommer HL and Pantel K: Tumor-antigen heterogeneity of disseminated breast cancer cells: implications for immunotherapy of minimal residual disease. Int J Cancer 84: 1-5, 1999.
17. Kuukasjarvi T, Karhu R, Tanner M, Kahkonen M, Schaffer A, Nupponen N, Pennanen S, Kallioniemi A, Kallioniemi OP and Isola J: Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 57: 1597-1604, 1997.
18. Pantel K, Schlimok G, Braun S, Kutter D, Lindemann F, Schaller G, Funke I, Izbicki JR and Riethmuller G: Differential expression of proliferation- associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst 85: 1419-1424, 1993.
19. Schlimok G, Funke I, Bock B, Schweiberer B, Witte J and Riethmuller G: Epithelial tumor cells in bone marrow of patients with colorectal cancer: immunocytochemical detection, phenotypic characterization, and prognostic significance. J Clin Oncol 8: 831-837, 1990.
20. Park S, Lee B, Kim I, Choi I, Hong K, Ryu Y, Rhim J, Shin J, Park SC, Chung H and Chung J: Immunobead RT-PCR versus regular RT-PCR amplification of CEA mRNA in peripheral blood. J Cancer Res Clin Oncol 127: 489-494, 2001.
21. Zhong XY, Kaul S, Lin YS, Eichler A and Bastert G: Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19. J Cancer Res Clin Oncol 126: 212-218, 2000.
22. Sabile A, Louha M, Bonte E, Poussin K, Vona G, Mejean A, Chretien Y, Bougas L, Lacour B, Capron F, Roseto A, Brechot C and Paterlini-Brechot P: Efficiency of Ber-EP4 antibody for isolating circulating epithelial tumor cells before RT-PCR detection. Am J Clin Pathol 112: 171-178, 1999.
23. Maas RA, Bruning PF, Breedijk AJ, Top B and Peterse HL: Immunomagnetic purification of human breast carcinoma cells allows tumor-specific detection of multidrug resistance gene 1-mRNA by reverse transcriptase polymerase chain reaction in fine-needle aspirates. Lab Invest 72: 760-764, 1995.
24. Berois N, Varangot M, Osinaga E, Babino A, Caignault L, Muse I and Roseto A: Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Anticancer Res 17: 2639-2646, 1997.
25. Naume B, Borgen E, Beiske K, Herstad TK, Ravnas G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S and Kvalheim G: Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 6: 103-114, 1997.
26. Umiel T, Prilutskaya M, Nguyen NH, Moss TJ, Schaeffer A, Burgess J, Griffith M and Mills B: Breast tumor contamination of peripheral blood stem cell harvests: increased sensitivity of detection using immunomagnetic enrichment. J Hematother Stem Cell Res 9: 895-904, 2000.
27. Treleaven JG, Gibson FM, Ugelstad J, Rembaum A, Philip T, Caine GD and Kemshead JT: Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1: 70-73, 1984.
28. Taback B, Chan AD, Kuo CT, Bostick PJ, Wang HJ, Giuliano AE and Hoon DS: Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Cancer Res 61: 8845-8850, 2001.
29. Bosma AJ, Weigelt B, Lambrechts AC, Verhagen OJ, Pruntel R, Hart AA, Rodenhuis S and van't Veer LJ: Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8: 1871-1877, 2002.